These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2400937

  • 1. Ganglioside composition of human melanoma and response to antitumor treatment.
    Kono K, Tsuchida T, Kern DH, Irie R.
    Cancer Invest; 1990; 8(2):161-7. PubMed ID: 2400937
    [Abstract] [Full Text] [Related]

  • 2. Modulation of ganglioside expression in human melanoma cell lines; increased resistance to chemo- and radiation treatment.
    Kunitomo K, Irie RF, Kern DH.
    Tokushima J Exp Med; 1992 Jun; 39(1-2):55-62. PubMed ID: 1384169
    [Abstract] [Full Text] [Related]

  • 3. Gangliosides of human melanoma.
    Tsuchida T, Saxton RE, Morton DL, Irie RF.
    J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
    [Abstract] [Full Text] [Related]

  • 4. Gangliosides of human melanoma.
    Tsuchida T, Saxton RE, Morton DL, Irie RF.
    Cancer; 1989 Mar 15; 63(6):1166-74. PubMed ID: 2917320
    [Abstract] [Full Text] [Related]

  • 5. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
    Lloyd KO, Gordon CM, Thampoe IJ, DiBenedetto C.
    Cancer Res; 1992 Sep 15; 52(18):4948-53. PubMed ID: 1516051
    [Abstract] [Full Text] [Related]

  • 6. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.
    Hoon DS, Irie RF, Cochran AJ.
    Cell Immunol; 1988 Feb 15; 111(2):410-9. PubMed ID: 3123073
    [Abstract] [Full Text] [Related]

  • 7. Ganglioside GD3 shedding by human malignant melanoma cells.
    Bernhard H, Meyer zum Büschenfelde KH, Dippold WG.
    Int J Cancer; 1989 Jul 15; 44(1):155-60. PubMed ID: 2744885
    [Abstract] [Full Text] [Related]

  • 8. The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.
    Thomas CP, Buronfosse A, Portoukalian J, Fertil B.
    Br J Cancer; 1997 Jul 15; 75(5):639-49. PubMed ID: 9043018
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of melanoma-associated gangliosides in cancer patients.
    Tai T, Cahan LD, Tsuchida T, Saxton RE, Irie RF, Morton DL.
    Int J Cancer; 1985 May 15; 35(5):607-12. PubMed ID: 3997282
    [Abstract] [Full Text] [Related]

  • 10. GD3 expression by cultured human tumor cells of neuroectodermal origin.
    He X, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Acta Neuropathol; 1989 May 15; 79(3):317-25. PubMed ID: 2609939
    [Abstract] [Full Text] [Related]

  • 11. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
    Hamilton WB, Helling F, Lloyd KO, Livingston PO.
    Int J Cancer; 1993 Feb 20; 53(4):566-73. PubMed ID: 8436430
    [Abstract] [Full Text] [Related]

  • 12. Differential roles of gangliosides in malignant properties of melanomas.
    Ohmi Y, Kambe M, Ohkawa Y, Hamamura K, Tajima O, Takeuchi R, Furukawa K, Furukawa K.
    PLoS One; 2018 Feb 20; 13(11):e0206881. PubMed ID: 30462668
    [Abstract] [Full Text] [Related]

  • 13. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
    Ravindranath MH, Tsuchida T, Morton DL, Irie RF.
    Cancer; 1991 Jun 15; 67(12):3029-35. PubMed ID: 2044049
    [Abstract] [Full Text] [Related]

  • 14. Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.
    Sjoberg ER, Varki A.
    J Biol Chem; 1993 May 15; 268(14):10185-96. PubMed ID: 8486686
    [Abstract] [Full Text] [Related]

  • 15. Characterization of gangliosides in human uveal melanoma cells.
    Soulieres D, Rousseau A, Deschenes J, Tremblay M, Tardif M, Pelletier G.
    Int J Cancer; 1991 Oct 21; 49(4):498-503. PubMed ID: 1917148
    [Abstract] [Full Text] [Related]

  • 16. Gangliosides of human melanoma: altered expression in vivo and in vitro.
    Tsuchida T, Ravindranath MH, Saxton RE, Irie RF.
    Cancer Res; 1987 Mar 01; 47(5):1278-81. PubMed ID: 3815339
    [Abstract] [Full Text] [Related]

  • 17. Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells.
    Hoon DS, Ando I, Sviland G, Tsuchida T, Okun E, Morton DL, Irie RF.
    Int J Cancer; 1989 May 15; 43(5):857-62. PubMed ID: 2714890
    [Abstract] [Full Text] [Related]

  • 18. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells.
    Cheresh DA, Harper JR, Schulz G, Reisfeld RA.
    Proc Natl Acad Sci U S A; 1984 Sep 15; 81(18):5767-71. PubMed ID: 6385004
    [Abstract] [Full Text] [Related]

  • 19. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
    Ruan S, Lloyd KO.
    Cancer Res; 1992 Oct 15; 52(20):5725-31. PubMed ID: 1394196
    [Abstract] [Full Text] [Related]

  • 20. Gangliosides of human melanoma: GM2 and tumorigenicity.
    Tsuchida T, Saxton RE, Irie RF.
    J Natl Cancer Inst; 1987 Jan 15; 78(1):55-60. PubMed ID: 3467130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.